rs73885319

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP5BP4BA1

The NM_003661.4(APOL1):​c.1024A>G​(p.Ser342Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0114 in 1,614,072 control chromosomes in the GnomAD database, including 2,158 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity,risk factor (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S342T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.062 ( 1084 hom., cov: 31)
Exomes 𝑓: 0.0061 ( 1074 hom. )

Consequence

APOL1
NM_003661.4 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity; risk factor criteria provided, conflicting classifications P:9U:2O:2

Conservation

PhyloP100: 0.277

Publications

339 publications found
Variant links:
Genes affected
APOL1 (HGNC:618): (apolipoprotein L1) This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
APOL1 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 4, susceptibility to
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP5
Variant 22-36265860-A-G is Pathogenic according to our data. Variant chr22-36265860-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity|risk_factor. ClinVar VariationId is 277678.
BP4
Computational evidence support a benign effect (MetaRNN=0.01211217). . Strength limited to SUPPORTING due to the PP5.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003661.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOL1
NM_003661.4
MANE Select
c.1024A>Gp.Ser342Gly
missense
Exon 6 of 6NP_003652.2
APOL1
NM_145343.3
c.1072A>Gp.Ser358Gly
missense
Exon 7 of 7NP_663318.1O14791-2
APOL1
NM_001136540.2
c.1024A>Gp.Ser342Gly
missense
Exon 6 of 6NP_001130012.1O14791-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOL1
ENST00000397278.8
TSL:1 MANE Select
c.1024A>Gp.Ser342Gly
missense
Exon 6 of 6ENSP00000380448.4O14791-1
APOL1
ENST00000319136.8
TSL:1
c.1072A>Gp.Ser358Gly
missense
Exon 7 of 7ENSP00000317674.4O14791-2
APOL1
ENST00000438034.6
TSL:4
c.1111A>Gp.Ser371Gly
missense
Exon 7 of 7ENSP00000404525.2B1AH94

Frequencies

GnomAD3 genomes
AF:
0.0624
AC:
9495
AN:
152060
Hom.:
1084
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.223
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0132
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.0340
GnomAD2 exomes
AF:
0.0161
AC:
4039
AN:
251414
AF XY:
0.0116
show subpopulations
Gnomad AFR exome
AF:
0.231
Gnomad AMR exome
AF:
0.00671
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000879
Gnomad OTH exome
AF:
0.00571
GnomAD4 exome
AF:
0.00609
AC:
8910
AN:
1461894
Hom.:
1074
Cov.:
36
AF XY:
0.00524
AC XY:
3810
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.237
AC:
7933
AN:
33480
American (AMR)
AF:
0.00729
AC:
326
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000495
AC:
55
AN:
1112012
Other (OTH)
AF:
0.00950
AC:
574
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
435
869
1304
1738
2173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0624
AC:
9496
AN:
152178
Hom.:
1084
Cov.:
31
AF XY:
0.0593
AC XY:
4410
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.222
AC:
9209
AN:
41460
American (AMR)
AF:
0.0131
AC:
201
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68024
Other (OTH)
AF:
0.0336
AC:
71
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
367
734
1101
1468
1835
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0207
Hom.:
1190
Bravo
AF:
0.0705
ESP6500AA
AF:
0.226
AC:
994
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.0206
AC:
2496
Asia WGS
AF:
0.00837
AC:
30
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity; risk factor
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Focal segmental glomerulosclerosis 4, susceptibility to (2)
-
1
-
APOL1-associated kidney disease (1)
1
-
-
Focal segmental glomerulosclerosis (1)
1
-
-
Focal segmental glomerulosclerosis;C0403397:Steroid-resistant nephrotic syndrome (1)
1
-
-
Focal segmental glomerulosclerosis;C2237347:Sickled erythrocytes (1)
1
-
-
Glomerulonephritis (1)
1
-
-
Nephrotic range proteinuria (1)
-
1
-
not provided (2)
1
-
-
Proteinuria (1)
-
-
-
Hyalinosis, Segmental Glomerular (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.77
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.11
DANN
Benign
0.092
DEOGEN2
Benign
0.026
T
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.00018
N
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-1.7
N
PhyloP100
0.28
PrimateAI
Benign
0.25
T
PROVEAN
Benign
4.5
N
REVEL
Benign
0.081
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.031
MPC
0.056
ClinPred
0.0012
T
GERP RS
-0.38
Varity_R
0.016
gMVP
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73885319; hg19: chr22-36661906; COSMIC: COSV59869297; COSMIC: COSV59869297; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.